These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 36820539)

  • 1. In-silico studies of inhibitory compounds against protease enzymes of SARS-CoV-2.
    Khan S; Nasrullah ; Hussain A; Asif M; Sattar FA; Audhal FA; Qadir MI; Hamdard MH
    Medicine (Baltimore); 2023 Feb; 102(6):e31318. PubMed ID: 36820539
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
    J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening of potent phytochemical inhibitors against SARS-CoV-2 protease and its two Asian mutants.
    Muhammad I; Rahman N; Gul-E-Nayab ; Niaz S; Basharat Z; Rastrelli L; Jayanthi S; Efferth T; Khan H
    Comput Biol Med; 2021 Jun; 133():104362. PubMed ID: 33894500
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Maurya AK; Mishra N
    J Biomol Struct Dyn; 2021 Nov; 39(18):7306-7321. PubMed ID: 32835632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthocyanin derivatives as potent inhibitors of SARS-CoV-2 main protease: An in-silico perspective of therapeutic targets against COVID-19 pandemic.
    Fakhar Z; Faramarzi B; Pacifico S; Faramarzi S
    J Biomol Struct Dyn; 2021 Oct; 39(16):6171-6183. PubMed ID: 32741312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promising inhibitors against main protease of SARS CoV-2 from medicinal plants:
    Ebenezer O; Shapi M
    Acta Pharm; 2022 Jun; 72(2):159-169. PubMed ID: 36651513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antiviral drugs based on inhibitors of the SARS-COV-2 main protease].
    Sulimov AV; Shikhaliev KS; Pyankov OV; Shcherbakov DN; Chirkova VY; Ilin IS; Kutov DC; Tashchilova AS; Krysin MY; Krylskiy DV; Stolpovskaya NV; Volosnikova EA; Belenkaya SV; Sulimov VB
    Biomed Khim; 2021 May; 67(3):259-267. PubMed ID: 34142533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Virtual screening, ADMET prediction and dynamics simulation of potential compounds targeting the main protease of SARS-CoV-2.
    Yadav R; Imran M; Dhamija P; Chaurasia DK; Handu S
    J Biomol Struct Dyn; 2021 Oct; 39(17):6617-6632. PubMed ID: 32715956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-silico pharmacophoric and molecular docking-based drug discovery against the Main Protease (Mpro) of SARS-CoV-2, a causative agent COVID-19.
    Haider Z; Subhani MM; Farooq MA; Ishaq M; Khalid M; Akram MN; Khan RSA; Niazi AK
    Pak J Pharm Sci; 2020 Nov; 33(6):2697-2705. PubMed ID: 33867348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial based natural compounds as potential inhibitors for SARS-CoV-2 Papain-like protease (PLpro): a molecular docking and dynamic simulation study.
    Rahul S; Sarkar A
    J Biomol Struct Dyn; 2022; 40(24):13848-13858. PubMed ID: 34730069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of multiple SARS-CoV-2 proteins by an antiviral biomolecule, seselin from
    Nivetha R; Bhuvaragavan S; Muthu Kumar T; Ramanathan K; Janarthanan S
    J Biomol Struct Dyn; 2022; 40(21):11070-11081. PubMed ID: 34431451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep learning model for virtual screening of novel 3C-like protease enzyme inhibitors against SARS coronavirus diseases.
    Kumari M; Subbarao N
    Comput Biol Med; 2021 May; 132():104317. PubMed ID: 33721736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of Novel SARS-CoV-2 Inhibitors by Combination of Machine Learning and Molecular Modeling Methods.
    Güner E; Özkan Ö; Yalcin-Ozkat G; Ölgen S
    Med Chem; 2024; 20(2):153-231. PubMed ID: 37957860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-silico approaches for identification of compounds inhibiting SARS-CoV-2 3CL protease.
    Zeyaullah M; Khan N; Muzammil K; AlShahrani AM; Khan MS; Alam MS; Ahmad R; Khan WH
    PLoS One; 2023; 18(4):e0284301. PubMed ID: 37058496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational identification of potential inhibitory compounds in Indian medicinal and aromatic plant species against major pathogenicity determinants of SARS-CoV-2.
    Sharma S; Sharma A; Bhattacharyya D; Chauhan RS
    J Biomol Struct Dyn; 2022; 40(24):14096-14114. PubMed ID: 34766880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Aloe-derived natural products as prospective lead scaffolds for SARS-CoV-2 main protease (M
    Hicks EG; Kandel SE; Lampe JN
    Bioorg Med Chem Lett; 2022 Jun; 66():128732. PubMed ID: 35427739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computer-aided drug design for the pain-like protease (PL
    Gao H; Dai R; Su R
    Biomed Pharmacother; 2023 Mar; 159():114247. PubMed ID: 36689835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
    Kumar Y; Singh H; Patel CN
    J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthetic flavonoids as potential antiviral agents against SARS-CoV-2 main protease.
    Batool F; Mughal EU; Zia K; Sadiq A; Naeem N; Javid A; Ul-Haq Z; Saeed M
    J Biomol Struct Dyn; 2022 May; 40(8):3777-3788. PubMed ID: 33251983
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.